(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drug

SEOUL, Nov. 5 (Yonhap) -- SK Biopharmaceuticals Co., a biopharmaceutical arm of ...

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.